ID   VGFR1_RAT               Reviewed;        1336 AA.
AC   P53767;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   02-OCT-2024, entry version 184.
DE   RecName: Full=Vascular endothelial growth factor receptor 1;
DE            Short=VEGFR-1;
DE            EC=2.7.10.1;
DE   AltName: Full=Fms-like tyrosine kinase 1;
DE            Short=FLT-1;
DE   AltName: Full=Tyrosine-protein kinase receptor FLT;
DE   Flags: Precursor;
GN   Name=Flt1; Synonyms=Flt-1, Vegfr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Fischer 344; TISSUE=Lung, and Testis;
RX   PubMed=8058332;
RA   Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G.,
RA   Shibuya M.;
RT   "A new communication system between hepatocytes and sinusoidal endothelial
RT   cells in liver through vascular endothelial growth factor and Flt tyrosine
RT   kinase receptor family (Flt-1 and KDR/Flk-1).";
RL   Oncogene 9:2683-2690(1994).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor
CC       for VEGFA, VEGFB and PGF, and plays an essential role in the
CC       development of embryonic vasculature, the regulation of angiogenesis,
CC       cell survival, cell migration, macrophage function, chemotaxis, and
CC       cancer cell invasion. Acts as a positive regulator of postnatal retinal
CC       hyaloid vessel regression (By similarity). May play an essential role
CC       as a negative regulator of embryonic angiogenesis by inhibiting
CC       excessive proliferation of endothelial cells. Can promote endothelial
CC       cell proliferation, survival and angiogenesis in adulthood. Its
CC       function in promoting cell proliferation seems to be cell-type
CC       specific. Promotes PGF-mediated proliferation of endothelial cells, and
CC       proliferation of some types of cancer cells, but does not promote
CC       proliferation of normal fibroblasts. Has very high affinity for VEGFA
CC       and relatively low protein kinase activity; may function as a negative
CC       regulator of VEGFA signaling by limiting the amount of free VEGFA and
CC       preventing its binding to KDR. Modulates KDR signaling by forming
CC       heterodimers with KDR. Ligand binding leads to the activation of
CC       several signaling cascades. Activation of PLCG leads to the production
CC       of the cellular signaling molecules diacylglycerol and inositol 1,4,5-
CC       trisphosphate and the activation of protein kinase C. Mediates
CC       phosphorylation of PIK3R1, the regulatory subunit of
CC       phosphatidylinositol 3-kinase, leading to the activation of
CC       phosphatidylinositol kinase and the downstream signaling pathway.
CC       Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase
CC       signaling pathway, as well as of the AKT1 signaling pathway.
CC       Phosphorylates SRC, YES1 and PLCG, and may also phosphorylate CBL.
CC       Promotes phosphorylation of AKT1 and PTK2/FAK1 (By similarity).
CC       {ECO:0000250|UniProtKB:P17948, ECO:0000250|UniProtKB:P35969}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. Binding of VEGFA, VEGFB or PGF leads to dimerization
CC       and activation by autophosphorylation on tyrosine residues (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with VEGFA, VEGFB and PGF. Monomer in the absence of
CC       bound VEGFA, VEGFB or PGF. Homodimer in the presence of bound VEGFA,
CC       VEGFB and PGF. Can also form a heterodimer with KDR. Interacts
CC       (tyrosine phosphorylated) with CBL, CRK, GRB2, NCK1, PIK3R1, PLCG,
CC       PSEN1 and PTPN11. Probably interacts with PTPRB. Interacts with RACK1.
CC       Identified in a complex with CBL and CD2AP (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endosome {ECO:0000250}. Note=Autophosphorylation promotes
CC       ubiquitination and endocytosis. {ECO:0000250}.
CC   -!- DOMAIN: The second and third Ig-like C2-type (immunoglobulin-like)
CC       domains are sufficient for VEGFA binding. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated after VEGFA-mediated autophosphorylation, leading to
CC       proteolytic degradation. {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues upon ligand binding.
CC       Autophosphorylation occurs in trans, i.e. one subunit of the dimeric
CC       receptor phosphorylates tyrosine residues on the other subunit.
CC       Phosphorylation at Tyr-1169 is important for interaction with PLCG.
CC       Phosphorylation at Tyr-1213 is important for interaction with PIK3R1,
CC       PTPN11, GRB2, and PLCG. Phosphorylation at Tyr-1331 is important for
CC       endocytosis and for interaction with CBL, NCK1 and CRK. Is probably
CC       dephosphorylated by PTPRB (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. CSF-1/PDGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D28498; BAA05857.1; -; mRNA.
DR   PIR; I60598; I60598.
DR   AlphaFoldDB; P53767; -.
DR   SMR; P53767; -.
DR   BioGRID; 248474; 1.
DR   IntAct; P53767; 1.
DR   MINT; P53767; -.
DR   STRING; 10116.ENSRNOP00000001248; -.
DR   GlyCosmos; P53767; 12 sites, No reported glycans.
DR   GlyGen; P53767; 12 sites.
DR   iPTMnet; P53767; -.
DR   PhosphoSitePlus; P53767; -.
DR   jPOST; P53767; -.
DR   PaxDb; 10116-ENSRNOP00000001248; -.
DR   Ensembl; ENSRNOT00055006086; ENSRNOP00055004608; ENSRNOG00055003840.
DR   UCSC; RGD:2621; rat.
DR   AGR; RGD:2621; -.
DR   RGD; 2621; Flt1.
DR   eggNOG; KOG0200; Eukaryota.
DR   InParanoid; P53767; -.
DR   PhylomeDB; P53767; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-194306; Neurophilin interactions with VEGF and VEGFR.
DR   Reactome; R-RNO-195399; VEGF binds to VEGFR leading to receptor dimerization.
DR   PRO; PR:P53767; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0019838; F:growth factor binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0036332; F:placental growth factor receptor activity; ISO:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; IDA:RGD.
DR   GO; GO:0005021; F:vascular endothelial growth factor receptor activity; IMP:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0048514; P:blood vessel morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; ISO:RGD.
DR   GO; GO:0048598; P:embryonic morphogenesis; ISS:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:1990384; P:hyaloid vascular plexus regression; ISS:UniProtKB.
DR   GO; GO:0030522; P:intracellular receptor signaling pathway; IMP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0002548; P:monocyte chemotaxis; ISO:RGD.
DR   GO; GO:1903671; P:negative regulation of sprouting angiogenesis; IDA:RGD.
DR   GO; GO:1905563; P:negative regulation of vascular endothelial cell proliferation; ISO:RGD.
DR   GO; GO:1904046; P:negative regulation of vascular endothelial growth factor production; IDA:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0060252; P:positive regulation of glial cell proliferation; IMP:RGD.
DR   GO; GO:1901534; P:positive regulation of hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:RGD.
DR   GO; GO:0048597; P:post-embryonic camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IDA:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0002040; P:sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0036323; P:vascular endothelial growth factor receptor-1 signaling pathway; ISO:RGD.
DR   CDD; cd00096; Ig; 2.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 7.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR001824; Tyr_kinase_rcpt_3_CS.
DR   InterPro; IPR041348; VEGFR-2_TMD.
DR   InterPro; IPR009135; VEGFR1_rcpt.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   PANTHER; PTHR24416:SF390; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1; 1.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13927; Ig_3; 2.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF22971; VEGFR-1-like_5th; 1.
DR   Pfam; PF21339; VEGFR-1-like_Ig-like; 1.
DR   Pfam; PF17988; VEGFR-2_TMD; 1.
DR   Pfam; PF22854; VEGFR1-3_N_Ig-like; 1.
DR   PIRSF; PIRSF000615; TyrPK_CSF1-R; 1.
DR   PRINTS; PR01832; VEGFRECEPTOR.
DR   PRINTS; PR01833; VEGFRECEPTR1.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 5.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 7.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 6.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00240; RECEPTOR_TYR_KIN_III; 1.
PE   2: Evidence at transcript level;
KW   Angiogenesis; ATP-binding; Cell membrane; Chemotaxis;
KW   Developmental protein; Differentiation; Disulfide bond; Endosome;
KW   Glycoprotein; Immunoglobulin domain; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase;
KW   Ubl conjugation.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   CHAIN           23..1336
FT                   /note="Vascular endothelial growth factor receptor 1"
FT                   /id="PRO_0000016770"
FT   TOPO_DOM        23..758
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        759..780
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        781..1336
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          32..121
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          151..214
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          230..327
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          335..421
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          429..549
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          556..655
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          661..747
FT                   /note="Ig-like C2-type 7"
FT   DOMAIN          827..1158
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          941..983
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1304..1326
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        941..957
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        958..975
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1022
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         833..841
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         861
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            767..768
FT                   /note="Cleavage; by PSEN1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         914
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   MOD_RES         1053
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1169
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   MOD_RES         1213
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   MOD_RES         1242
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   MOD_RES         1325
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   MOD_RES         1331
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P17948"
FT   CARBOHYD        100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        196
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        251
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        323
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        474
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        516
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        597
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        625
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        666
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        713
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        53..107
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        158..207
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        252..311
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        454..535
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        577..636
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        682..731
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   1336 AA;  150250 MW;  0CCCD68C1F3D20CE CRC64;
     MVSCWDTAVL PCALLGCLLL TGYCSGSKLK GPELSLKGTQ HVMQAGQTLF LKCRGEAAHS
     WSLPTTVSQE DKKLSVTRSA CGRNNRQFCS TLTLNMAQAN HTGLYSCRYL PKSTSKEKKM
     ESAIYIFVSD AGSPFIEMHS DIPKLVHMTE GRELIIPCRV TSPNITVTLK KFPFDALTPD
     GQRIAWDSRR GFIIANATYK EIGLLTCEAT VNGHLYQTSY LTHRQTNTIL DVQISPPSPV
     RFLRGQTLVL NCTVTTDLNT RVQMSWNYPG KATKRASIRQ RIDQSNPHSN VFHSVLKINN
     VESRDKGLYT CRVKSGSSFR TFNTSVHVYE KGFISVKHRK QQVQETIAGK RSHRLSMKVK
     AFPSPEVVWL KDGVPATEKS ARYSVHGYSL IIKDVTAEDA GDYTILLGIK QSKLFRNLTA
     TLIVNVKPQI YEKSVSSLPS PPLYPLGSRQ VLTCTVYGIP QPTIKWLWHP CHYNHSKERN
     DFCFGSEESF ILDSSSNIGN RIEGITQRMM VIEGTNKTVS TLVVADSRTP GSYSCKAFNK
     IGTVERDIRF YVTDVPNGFH VSLEKIPTEG EDLKLSCVVS KFLYRDITWI LLRTVNNRTM
     HHSISKQKMA TTQDYSITLN LVIKNVSLED SGTYACRARN IYTGEEILRK TEVLVRDLEA
     PLLLQNLSDH EVSISGSTTL DCQARGVPAP QITWFKNNHK IQQEPGIILG PGNSTLFIER
     VTEEDEGVYR CRATNQKGVV ESSAYLTVQG TSDKSNLELI TLTCTCVAAT LFWLLLTLFI
     RKLKRSSSEV KTDYLSIIMD PDEVPLDEQC ERLPYDASKW EFARERLKLG KSLGRGAFGK
     VVQASAFGIK KSPTCRTVAV KMLKEGATAS EYKALMTELK ILTHIGHHLN VVNLLGACTK
     QGGPLMVIVE YCKYGNLSNY LKSKRDFFCL NKDAALHMEP KKEKLEPDLE QDQKPRLDSV
     SSSESFTSSG FQEDKSVSDV EGGEDYSEIS KQPLTMEDLI SYSFQVARGM EFLSSRKCIH
     RDLAARNILL SENNVVKICD FGLARDIYKN PDYVRRGDTR LPLKWMAPES IFDKVYSTKS
     DVWSYGVLLW EIFSLGGSPY PGVQMDEDFC SRLKEGMRMR TPEYATPEIY QIMLDCWHKD
     PKERPRFAEL VEKLGDLLQA NVQQDGKDYI PLNAILTRNS GFTYSVPTFS EDFFKDGFTD
     PKFHSGSSDD VRYVNAFKFM SLERIKTFEE LSPNATSMFE DYHLDTSSLL TSPLLKRFTW
     TETKPKASMK IDLRITSKSK EAGLSDLPGP SFCFSSCGHI RPVRQEDEDD PELGKESCCS
     PPPDYNSVVL YSSPPA
//
